Kymera Therapeutics, Inc.

KYMR

—

Advanced chart & tools →

Kymera Therapeutics, Inc.KYMR

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.69

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$39.21M

Net income

$-311.35M

Net margin

-794.0%

Gross margin

—

Dividends & financials

Kymera Therapeutics, Inc. (KYMR) reported revenue of $39.21M and net income of $-311.35M, or $-3.69 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.